Skip to main content
. Author manuscript; available in PMC: 2009 Mar 20.
Published in final edited form as: J Neurooncol. 2008 Jan 30;88(1):43–50. doi: 10.1007/s11060-008-9530-8

Figure 2.

Figure 2

Kaplan-Meier graph of progression-free survival, stratified by protocol. Dashed line = Adjuvant temozolomide only (group 1). Solid line = concurrent and adjuvant treatment temozolomide (group 2). The difference between these curves is not statistically significant (log-rank p=0.2159).